D. E. Shaw & Co., Inc. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 103 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$395,581
-76.1%
1,073,491
-72.1%
0.00%
-100.0%
Q3 2022$1,654,000
-73.7%
3,844,988
-52.2%
0.00%
-71.4%
Q2 2022$6,281,000
-37.9%
8,051,858
+2.6%
0.01%
-22.2%
Q1 2022$10,121,000
+823.4%
7,845,726
+809.5%
0.01%
+800.0%
Q4 2021$1,096,000
+99.3%
862,637
+241.5%
0.00%
Q3 2021$550,000
-74.4%
252,625
-55.9%
0.00%
-100.0%
Q2 2021$2,151,000
+26.0%
573,398
+9.5%
0.00%0.0%
Q1 2021$1,707,000
-55.8%
523,839
-53.7%
0.00%
-33.3%
Q4 2020$3,860,000
+0.6%
1,131,840
+20.3%
0.00%
-25.0%
Q3 2020$3,838,000
-27.1%
940,784
-39.6%
0.00%
-33.3%
Q2 2020$5,266,000
+236.9%
1,558,075
+132.3%
0.01%
+200.0%
Q1 2020$1,563,000
+89.0%
670,606
+195.0%
0.00%
+100.0%
Q4 2019$827,000
+21.8%
227,308
+462.3%
0.00%0.0%
Q3 2018$679,000
-92.4%
40,426
-90.6%
0.00%
-91.7%
Q2 2018$8,968,000
-59.3%
427,847
-68.8%
0.01%
-60.0%
Q1 2018$22,054,000
-41.5%
1,370,617
-31.1%
0.03%
-42.3%
Q4 2017$37,682,000
-6.0%
1,988,477
-30.2%
0.05%
-16.1%
Q3 2017$40,088,000
+117.1%
2,849,168
+14.9%
0.06%
+100.0%
Q2 2017$18,467,000
+19.6%
2,478,787
+4.4%
0.03%
+14.8%
Q1 2017$15,437,000
+65.2%
2,374,848
+12.6%
0.03%
+68.8%
Q4 2016$9,347,000
-0.9%
2,109,895
+4.5%
0.02%
-5.9%
Q3 2016$9,431,000
-31.9%
2,019,370
-4.2%
0.02%
-34.6%
Q2 2016$13,853,000
+75.8%
2,108,614
+70.2%
0.03%
+85.7%
Q1 2016$7,879,000
+32.4%
1,238,760
+25.5%
0.01%
+55.6%
Q4 2015$5,952,000
+95.0%
987,110
+93.3%
0.01%
+125.0%
Q3 2015$3,053,000
+825.2%
510,634
+959.2%
0.00%
Q2 2015$330,000
-32.0%
48,209
-39.7%
0.00%
-100.0%
Q1 2015$485,000
-55.3%
79,891
-40.2%
0.00%0.0%
Q2 2014$1,086,000
+570.4%
133,573
+545.4%
0.00%
Q1 2014$162,000
-93.6%
20,697
-92.8%
0.00%
-100.0%
Q4 2013$2,532,000
-77.3%
286,096
-78.5%
0.00%
-83.3%
Q3 2013$11,142,000
+24.2%
1,328,061
+10.5%
0.02%
+5.9%
Q2 2013$8,969,0001,202,2810.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders